These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 10351962)

  • 1. Combined thrombolytic and platelet glycoprotein IIb/IIIa inhibitor therapy for acute myocardial infarction: will pharmacological therapy ever equal primary angioplasty?
    Kennedy JW; Stadius ML
    Circulation; 1999 Jun; 99(21):2714-6. PubMed ID: 10351962
    [No Abstract]   [Full Text] [Related]  

  • 2. GPIIbIIIa inhibitors as adjunctive therapy in acute myocardial infarction.
    Salame M; Verheye S; More R; King SB; Chronos N
    Int J Cardiol; 1999 Jun; 69(3):231-6. PubMed ID: 10402105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet glycoprotein IIB/IIIA receptor antagonists. An asset for treatment of unstable coronary syndromes and coronary intervention.
    Ronner E; Dykun Y; van den Brand MJ; van der Wieken LR; Simoons ML
    Eur Heart J; 1998 Nov; 19(11):1608-16. PubMed ID: 9857912
    [No Abstract]   [Full Text] [Related]  

  • 4. Indications for appropriate platelet glycoprotein IIb/IIIa inhibitor therapy.
    Rokos I
    Ann Emerg Med; 2002 Apr; 39(4):457-8; author reply 458-9. PubMed ID: 11919540
    [No Abstract]   [Full Text] [Related]  

  • 5. Conjunctive use of platelet glycoprotein IIb/IIIa antagonists and thrombolytic therapy for acute myocardial infarction.
    Moliterno DJ; Topol EJ
    Thromb Haemost; 1997 Jul; 78(1):214-9. PubMed ID: 9198156
    [No Abstract]   [Full Text] [Related]  

  • 6. [Intracoronary thrombolysis combined with platelet receptor IIb/IIIa inhibitor and followed by percutaneous coronary intervention for the treatment of acute myocardial infarction: two case reports].
    Bryniarski L; Jankowski P; Dragan J; Dudek D; Kawecka-Jaszcz K
    Kardiol Pol; 2004 Mar; 60(3):255-9. PubMed ID: 15156222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Facilitated percutaneous coronary intervention in acute myocardial infarction: attractive concept but difficult to prove!
    Kelly RV; Cohen MG; Ohman EM
    Am Heart Hosp J; 2004; 2(4):211-22. PubMed ID: 15538055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GUSTO IV: expanding therapeutic options in acute coronary syndromes.
    Lincoff AM
    Am Heart J; 2000 Dec; 140(6 Suppl):S103-14. PubMed ID: 11100004
    [No Abstract]   [Full Text] [Related]  

  • 9. [Platelet glycoprotein IIb/IIIa inhibitors in coronary artery disease].
    Auer J; Berent R; Lassnig E; Weber T; Maurer E; Eber B
    Herz; 2003 Aug; 28(5):393-403. PubMed ID: 12928738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Logic and logistics: conundrum in reperfusion treatment for acute myocardial infarction.
    Brener S; Topol EJ
    Heart; 1999 Oct; 82(4):402-3. PubMed ID: 10490544
    [No Abstract]   [Full Text] [Related]  

  • 11. Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial.
    Pereira H;
    Rev Port Cardiol; 2001 Jun; 20(6):687-8. PubMed ID: 11525077
    [No Abstract]   [Full Text] [Related]  

  • 12. [Glycoprotein IIb/IIIa platelet blockers in acute myocardial infarct treated with primary coronary angioplasty].
    Kala P; Poloczek M; Bocek O; Jerábek P; Neugebauer P; Kosová J; Semrád B
    Vnitr Lek; 2002 Aug; 48(8):736-41. PubMed ID: 12425204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early vs late administration of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention of acute ST-segment elevation myocardial infarction: a meta-analysis.
    Montalescot G; Borentain M; Payot L; Collet JP; Thomas D
    JAMA; 2004 Jul; 292(3):362-6. PubMed ID: 15265852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials.
    Boersma E; Harrington RA; Moliterno DJ; White H; Théroux P; Van de Werf F; de Torbal A; Armstrong PW; Wallentin LC; Wilcox RG; Simes J; Califf RM; Topol EJ; Simoons ML
    Lancet; 2002 Jan; 359(9302):189-98. PubMed ID: 11812552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Impact of GP IIb/IIIa antagonists in interventional cardiology].
    Scheller B; Hennen B; Böhm M; Nickenig G
    Dtsch Med Wochenschr; 2003 Feb; 128(6):281-7. PubMed ID: 12571800
    [No Abstract]   [Full Text] [Related]  

  • 16. Glycoprotein IIb/IIIa receptor inhibitor-thrombolytic combination therapy for acute myocardial infarction.
    Maranian AM; Steinhubl SR
    Curr Cardiol Rep; 2002 Jul; 4(4):313-9. PubMed ID: 12052270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycoprotein IIb/IIIa inhibition.
    Horton H
    JAMA; 2004 Nov; 292(18):2211; author reply 2211-2. PubMed ID: 15536102
    [No Abstract]   [Full Text] [Related]  

  • 18. Glycoprotein IIb/IIIa antagonist and fibrinolytic agents: new therapeutic regimen for acute myocardial infarction.
    Patel VB; Moliterno DJ
    J Invasive Cardiol; 2000 Mar; 12 Suppl B():8B-15B. PubMed ID: 10731294
    [No Abstract]   [Full Text] [Related]  

  • 19. Do new devices add to the results of PTCA in acute myocardial infarction?
    Moses J; Moussa I
    Am Heart J; 1999 Aug; 138(2 Pt 2):S158-63. PubMed ID: 10426876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombolysis in elderly patients with acute myocardial infarction.
    Berger AK
    Am J Geriatr Cardiol; 2003; 12(4):251-6; quiz 257. PubMed ID: 12888706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.